Mesenchymal stem cell‐derived exosomes in preeclampsia: A next‐generation therapeutic tool
Cell Biochemistry and Function · 2024
DOI: 10.1002/cbf.3908 ↗At a glance
Übersichtsarbeit in Cell Biochemistry and Function, 2024. Written by Ria Margiana. Institution: Department of Anatomy, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia. Major MEDLINE topics: Exosomes, Pre-Eclampsia, Mesenchymal Stem Cells. Cited 4 times so far (Crossref); 155 references.
Abstract (original language)
Preeclampsia (PE) is a major gestational disorder that causes both long‐ and short‐term damage to both the mother and the fetus. Endometrium decidualization and the formation of the placenta are orchestrated by mesenchymal stem cells (MSCs). MSCs obtained from patients with PE exhibit an elevated rate of aging and apoptosis, which impairs the interplay between MSCs and endothelium, trophoblast, and immune cells in the placenta, accelerating the onset of PE. Preclinical and clinical evidence imply that the MSC‐based therapy approach for PE is prospective. Importantly, as a novel cell‐free approach, MSC‐derived exosomes can improve symptoms and maternal–fetal survival in PE models by raising cell metabolism, encouraging angiogenesis balance, and regulating immune responses. Even following allogeneic administration, the likelihood of immune rejection is very limited as a result of the small quantity of exosome membrane‐bound proteins. Furthermore, because exosomes do not expand, developing tumors is not probable. As a result, MSC‐derived exosomes show superiority over MSCs in terms of safety. For the first time, we outline the properties of MSC‐exosomes and highlight their functions and potential as a new paradigm for PE therapy in this review.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Anatomy, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
- Master's Programme Biomedical Sciences, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
- Andrology Program, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
- Dr. Soetomo General Academic Hospital, Surabaya, Indonesia.
Cite
APA
Margiana, R. (2024). Mesenchymal stem cell‐derived exosomes in preeclampsia: A next‐generation therapeutic tool. Cell Biochemistry and Function. https://doi.org/10.1002/cbf.3908
Vancouver
Margiana R. Mesenchymal stem cell‐derived exosomes in preeclampsia: A next‐generation therapeutic tool. Cell Biochemistry and Function. 2024. doi:10.1002/cbf.3908
BibTeX
@article{Margiana2024,
author = {Margiana, Ria},
title = {Mesenchymal stem cell‐derived exosomes in preeclampsia: A next‐generation therapeutic tool},
journal = {Cell Biochemistry and Function},
year = {2024},
doi = {10.1002/cbf.3908}
}
EUVIMED